# Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata

> **NCT04161456** · PHASE2 · COMPLETED · sponsor: **Dr. Frank Behrens** · enrollment: 1 (actual)

## Conditions studied

- Acne Conglobata

## Interventions

- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT04161456
- **Lead sponsor:** Dr. Frank Behrens
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-09
- **Primary completion:** 2021-02-08
- **Final completion:** 2021-02-08
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2022-03-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04161456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04161456, "Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04161456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*